FSMAX
Price
$103.54
Change
+$1.43 (+1.40%)
Updated
Feb 3 closing price
Net Assets
40.63B
LMREX
Price
$31.00
Change
-$3.16 (-9.25%)
Updated
Feb 3 closing price
Net Assets
1.61B
Interact to see
Advertisement

FSMAX vs LMREX

Header iconFSMAX vs LMREX Comparison
Open Charts FSMAX vs LMREXBanner chart's image
Fidelity Extended Market Index
Price$103.54
Change+$1.43 (+1.40%)
VolumeN/A
Net Assets40.63B
ClearBridge Mid Cap R
Price$31.00
Change-$3.16 (-9.25%)
VolumeN/A
Net Assets1.61B
FSMAX vs LMREX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. LMREX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LMREX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.6B vs. LMREX (1.61B). FSMAX pays higher dividends than LMREX: FSMAX (0.56) vs LMREX (0.00). FSMAX was incepted earlier than LMREX: FSMAX (14 years) vs LMREX (17 years). LMREX (1.46) is less costly to investors than FSMAX (0.04). LMREX is a more actively managed with annual turnover of: 36.00 vs. FSMAX (15.00). FSMAX (0) and LMREX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 10.51 vs. LMREX (-6.68). FSMAX return over 5 years is better than : 19.23 vs. LMREX (-18.23).
FSMAXLMREXFSMAX / LMREX
Total Expense Ratio0.041.452%
Annual Report Gross Expense Ratio0.041.462%
Fund Existence14 years17 years-
Gain YTD3.0502.074147%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40.6B1.61B2,519%
Annual Yield % from dividends0.560.00-
Returns for 1 year10.51-6.68-157%
Returns for 3 years48.06-1.65-2,913%
Returns for 5 years19.23-18.23-106%
Returns for 10 years157.0222.59695%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTHP0.460.03
+7.10%
Guided Therapeutics, Inc.
IDTA0.17N/A
N/A
Identa Corp.
NLLSY6.51N/A
N/A
Nel ASA
PPAAY5.77N/A
N/A
PT Perusahaan Gas Negara Persaro
SNNUF17.05N/A
N/A
Smith & Nephew PLC